RLS (USA) INC.

Capabilities

RLS is committed to maintaining high standards in the industry, from agent compounding to customer delivery. Our continuous focus on safety has created an innovative WBC labeling process that supports patient blood integrity. RLS (Radioisotope Life Sciences) sees itself as a key role player to facilitate the entry of new drugs and the installation of state of the art imaging equipment into the practice of health care. We also commit to expanding the market through alternative methods of production for Tc-99m and Ga-68. RLS maintains high-quality standards by routinely upgrading operational procedures to provide the best available practices. One of our key services is the procedure of radiolabeling autologous leukocytes (WBC labeling process). We have also implemented a uniquely keyed locking system to ensure limited access during the entire labeling process.